
Genome sequencing recommended as first-line test
The American Academy of Pediatrics (AAP) now recommends whole genome sequencing (WGS) as a first-line test for children with global developmental delay and intellectual disability (GDD/ID) when no clear diagnosis is suspected.
Benefits of Whole Genome Sequencing
How Jura Health Helps:
Jura Health delivers an ultra-comprehensive solution for each patient that is clear, actionable, personalized, and designed to remain relevant over time. Every test includes: